E1a is an exogenous in vivo tumour suppressor-Reference-Cited by-同舟云学术

E1a is an exogenous in vivo tumour suppressor

Published:2017-07 Issue: Volume:399 Page:74-81
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Cimas Francisco J.,Callejas-Valera Juan L.,García-Olmo Dolores C.,Hernández-Losa Javier,Melgar-Rojas Pedro,Ruiz-Hidalgo María J.^ORCID,Pascual-Serra Raquel,Ortega-Muelas Marta,Roche Olga,Marcos Pilar,Garcia-Gil Elena,Fernandez-Aroca Diego M.,Ramón y Cajal Santiago,Gutkind J. Silvio,Sanchez-Prieto Ricardo^ORCID

Funder

Fundación Leticia Castillejo Castillo and MINECO

JCCM

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes;Franza;Cell,1986

2. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product;Kaelin;Cell,1991

3. Antioncogenic effect of adenovirus E1A in human tumour cells;Frisch;Proc. Natl. Acad. Sci. U. S. A.,1991

4. Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene;Sanchez-Prieto;Oncogene,1996

5. The anti-tumour activity of E1A and its implications in cancer therapy;Chang;Arch. Immunol. Ther. Exp.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study;Clinical and Translational Radiation Oncology;2023-07

2. MAPK11 (p38β) is a major determinant of cellular radiosensitivity by enhancing IR-associated senescence;2022-09-13

3. Tilting MYC toward cancer cell death;Trends in Cancer;2021-11

4. Analysis of E1A domains involved in the enhancement of CDK2 activity;Biochemical and Biophysical Research Communications;2021-04

5. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy;IUBMB Life;2021-03-03